Cohen EEW, Nabell L, Wong DJ, Day T, et al. Intralesional SD-101 in combination with pembrolizumab in anti-PD-1 treatment naive head and neck squamous cell carcinoma: results from a multicenter, phase 2 trial. Clin Cancer Res 2021 Dec 29. pii: 1078-0432.CCR-21-1411.
PMID: 34965944